Suppr超能文献

日本50岁以下女性的乳腺钼靶筛查

Breast cancer screening by mammography in women aged under 50 years in Japan.

作者信息

Morimoto T, Sasa M, Yamaguchi T, Kondo H, Akaiwa H, Sagara Y

机构信息

School of Medical Sciences, University of Tokushima, 3-18-15 Kuramoto-cho, Tokushima 770, Japan.

出版信息

Anticancer Res. 2000 Sep-Oct;20(5C):3689-94.

Abstract

BACKGROUND

The effectiveness of mammographic screening in women aged over 50 years has been confirmed in the United States and Europe, but its effectiveness in women aged from 40 to 49 years remains controversial. The optimum age for effective screening of subjects for breast cancer by mammography in Japan was studied based on the results of mammographic screening.

METHOD

The benefit of breast cancer screening in women was examined by stratifying the results of mammographic screening in a Tokushima trial on the basis of age: under 50 years and 50 years or older. The results of conventional screening by physical examination alone, which we performed in a Zentsuji trial, were used as the control.

RESULTS

The examinees numbered 13,982 and 18,619 in mammographic screening and screening by physical examination, respectively. Breast cancer was detected in 43 and 22 patients, respectively. The detection rate of breast cancer was 0.31% by mammographic screening, which is about 3 times higher than that (0.12%) by screening using physical examination. Mammographic screening thus showed significantly higher sensitivity (93.5% vs 73.3%, p = 0.015). The proportion of stage I cancer and the absence of nodal involvement were 67.4% and 79.1% by mammographic screening, compared with 31.8% and 59% by physical examination. Our results obtained with mammographic screening were equal to or higher than the results obtained in the United States and Europe. The clinical stage of the breast cancers detected by mammographic screening in the subjects aged under 50 years was stage 0 (DCIS) in one case and stage I in 10 cases, while the group aged 50 years or older showed stage 0 in 11 cases and stage I in 19 cases. There were three cases of false-negative; two false-negative cases were aged under 50 year, while one case was aged 50 years or older. The detection rates of cancer in the group under 50 years and that of 50 years or more were 0.19% and 0.39% by mammograpic screening and 0.09% and 0.15% by the physical examination. The sensitivities in the group under 50 years and that of 50 years or more were 84.6% and 97.0% by mammographic screening and 72.7% and 73.7% by physical examination, showing no significant difference. In the results of mammograms by Wolfe's classification with respect to the age groups, the proportion of DY (dense breast) pattern decreased significantly from 3.5% to 0.2% in women of 50 years or more and from 16.6% to 2.4% in those under 50 years when the values were compared between the period from 1992 to 1995 and the period from 1998 to 1999, respectively (p < 0.0001).

CONCLUSION

The above findings suggested the possible effectiveness of mammographic screening not only in women aged 50 years or more but also in those aged under 50 years, in Japan. Therefore, introduction of mammography should be considered at an early date, even for women aged from 40 to 49 years.

摘要

背景

乳腺钼靶筛查在50岁以上女性中的有效性已在美国和欧洲得到证实,但其在40至49岁女性中的有效性仍存在争议。基于乳腺钼靶筛查结果,对日本通过钼靶进行乳腺癌有效筛查的最佳年龄进行了研究。

方法

通过在德岛试验中根据年龄(50岁以下和50岁及以上)对乳腺钼靶筛查结果进行分层,来检验女性乳腺癌筛查的益处。将我们在善通寺试验中仅通过体格检查进行的传统筛查结果用作对照。

结果

乳腺钼靶筛查和体格检查的受检者分别为13982人和18619人。分别在43例和22例患者中检测到乳腺癌。乳腺钼靶筛查的乳腺癌检出率为0.31%,约为体格检查筛查(0.12%)的3倍。因此,乳腺钼靶筛查显示出显著更高的敏感性(93.5%对73.3%,p = 0.015)。乳腺钼靶筛查的I期癌症比例和无淋巴结受累比例分别为67.4%和79.1%,而体格检查分别为31.8%和59%。我们通过乳腺钼靶筛查获得的结果等于或高于在美国和欧洲获得的结果。在50岁以下受试者中通过乳腺钼靶筛查检测到的乳腺癌临床分期,1例为0期(导管原位癌),10例为I期,而50岁及以上组11例为0期,19例为I期。有3例假阴性病例;2例假阴性病例年龄在50岁以下,1例年龄在50岁及以上。50岁以下组和50岁及以上组通过乳腺钼靶筛查的癌症检出率分别为0.19%和0.39%,通过体格检查分别为0.09%和0.15%。50岁以下组和50岁及以上组通过乳腺钼靶筛查的敏感性分别为84.6%和97.0%,通过体格检查分别为72.7%和73.7%,无显著差异。在按沃尔夫分类法对年龄组进行乳腺钼靶检查的结果中,将1992年至1995年期间与1998年至1999年期间的值进行比较时,50岁及以上女性中DY(致密乳腺)型的比例从3.5%显著降至0.2%,50岁以下女性中从16.6%降至2.4%(p < 0.0001)。

结论

上述发现表明,在日本,乳腺钼靶筛查不仅对50岁及以上女性可能有效,对50岁以下女性也可能有效。因此,即使对于40至49岁的女性,也应尽早考虑引入乳腺钼靶检查。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验